<DOC>
	<DOCNO>NCT02055508</DOCNO>
	<brief_summary>The investigator plan evaluate , randomize , control phase III trial patient advance non-small cell lung cancer ( NSCLC ) , effect 24-week exercise intervention program ( EIP ) quality life , physical functioning immune function parameter . Eligible patient ( n=250 ) enrol Clinic Thoracic Diseases , Heidelberg , time period two year follow total 12 month . Patients randomize either EIP plus Care Management Phone Calls ( CMPC ) versus CMPC alone ( besides proper symptom side effect management CMPC ensure potential influence social contact anticipate patient intervention group ) . Our primary aim investigate whether combination partly supervise ( in- outpatient ) partly home-based endurance resistance training improve quality life ( QoL ) lower level fatigue ( evaluation via standardized validated questionnaire FACT-L MFI ) . In addition propose evaluate effect EIP tumor specific immune response . Biomarkers immune function measure cellular immunity cytokine chemokine panel . Further secondary outcome include measurement anxiety , depression demoralization , physical performance parameter ( e.g . improvement walk distance , muscle strength ) , well overall progression free survival analysis . The study build previous feasibility study 8 week exercise intervention trial patient advance NSCLC result utilized design propose trial . The investigator hypothesize patient randomize exercise intervention group show improve QoL reduce fatigue , well improve physical functioning increase tumor specific immune response .</brief_summary>
	<brief_title>POSITIVE - Study ( Part III ) Heidelberg</brief_title>
	<detailed_description />
	<criteria>NSCLC stage IIIB/IV receive systemic treatment ( palliative radiotherapy accept ) BMI &gt; 18 ECOG ( Eastern Cooperative Oncology Group ) performance status â‰¤ 2 sign inform consent serious active infection ( i.e . require iv antibiotic , antifungal antiviral agent ) inability walk immobility ( two day ) previously untreated ( nonirradiated nonresected ) symptomatic brain metastasis ; permit : ( 1 ) previously treat brain metastasis [ radiotherapy , surgery , dexamethasone dosage 8 mg per day , antiepileptic therapy ] ; ( 2 ) asymptomatic brain metastasis without additional therapy requirement severe neurologic impairment ( e.g . apoplectic insult , Morbus Parkinson , par extremity ) severe cardiac impairment ( e.g . cardiac insufficiency NYHA ( New York Heart Association ) &gt; III , myocardial infarction within last three month , unexplained syncopal event , severe cardiac arrhythmia , high grade aortic stenosis ) severe respiratory insufficiency uncontrolled pain abuse alcohol drug reduce compliance study bone metastasis induce skeletal fragility circumstance would impede ability give inform consent adherence study requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Exercise</keyword>
	<keyword>Physical Activity</keyword>
	<keyword>Palliative Care</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>NSCLC</keyword>
</DOC>